Inventor · disambiguated record
Karl H. Weisgraber
Also filed as: WEISGRABER KARL · WEISGRABER KARL H
6 granted patents·4 pending applications·28 citations·filing 1996–2011
79Inventor score
Top patents by PatentIndex Score
10 records- 0184US9102717B2Antibody specific for apolipoprotein and methods of use thereofHUANG YADONG·Filed 2011·Granted Aug 11, 2015·12 cites·20 claims
- 0275US7964598B2ApoE4 domain interaction inhibitors and methods of use thereofDAVID GLADSTONE INST·Filed 2005·Granted Jun 21, 2011·3 cites·5 claims
- 0366US7960606B2Mouse model of chronic heart failure and coronary atherosclerosis regressionDAVID GLADSTONE INST·Filed 2007·Granted Jun 14, 2011·4 cites·4 claims
- 0465US7081561B2Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereofUNIV CALIFORNIA·Filed 2001·Granted Jul 25, 2006·1 cites·6 claims
- 0554US2009017558A1Apolipoprotein e stable folding intermediate and methods of use thereofWEISGRABER KARL H·Filed 2008·Application pending·0 cites
- 0650US2012129782A1Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related DisordersHUANG YADONG·Filed 2009·Application pending·0 cites
- 0748US2006230466A1Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereofWEISGRABER KARL H·Filed 2006·Application pending·0 cites
- 0841US7432355B2Apolipoprotein E stable folding intermediate and methods of use thereofDAVID GLADSTONE INST·Filed 2003·Granted Oct 7, 2008·0 cites·10 claims
- 0938US5811243AMethods and compositions for binding tau and MAP2c proteinsUNIV DUKE·Filed 1996·Granted Sep 22, 1998·8 cites·6 claims
- 1036US2002009439A1Compounds effecting neuron remodeling and assays for sameFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →